Global Cancer Monoclonal Antibodies Market Size, by Product Type, Application, & Region – Key Manufacturers, Analysis, Growth Trends, and Forecast till 2025

This report studies the global Cancer Monoclonal Antibodies market status and forecast, categorizes the global Cancer Monoclonal Antibodies market size (value & volume) by manufacturers, type, application, and region. This report focuses on the top manufacturers in North America, Europe, Japan, China, India, Southeast Asia and other regions (Central & South America, and Middle East & Africa).

The mAbs, which are produced by genetic engineering, target antigens in cells, tissues, and organs. They are used in clinical applications to treat diseases with excellent efficacy and minimal side effects. Their MOA, absence of generic pathway, and therapeutic applications distinguish them from other targeted therapeutics.
Cancer is one of the leading causes of death globally. There were 10.9 million new cases, in 2002, which increased to 14.1 million, in 2012 (approximately 30% growth in a decade). The WHO expects this number to increase by 70%, over the next two decades. According to the WHO, almost 70% of deaths occur in low and middle-income countries. The increment in data is expected to provide the basis for any national policy on cancer, leading to an increase in the percentage of people choosing cancer treatment. In the healthcare sector, cancer is one of the biggest concerns. Thus, the increased use of monoclonal antibodies for the treatment of cancer is driving this market.
Monoclonal Antibodies having the potential to offer less toxic and efficient therapeutic alternatives to the patients have been emerging in the recent years. Monoclonal Antibodies are used to treat a wide array of diseases related to autoimmune, inflammatory and especially cancer. Monoclonal Antibodies (mAbs) are mono-specific antibodies bodies comprising of identical immune cells that are clones of a single parent cells and are directed to a specific cellular targets. Thus Monoclonal Antibodies are highly customizable due to its specific nature and can play a crucial role in eliminating the cancerous cell while sparing the normal cells during the cancer treatment. The monoclonal antibodies are proved to be more effective than chemotherapies and drugs for cancer treatment.
The global Cancer Monoclonal Antibodies market is valued at xx million US$ in 2017 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2018-2025.

The major manufacturers covered in this report
F. Hoffmann-La Roche
Amgen
Bristol-Myers Squibb
Takeda Pharmaceuticals
...

Geographically, this report studies the top producers and consumers, focuses on product capacity, production, value, consumption, market share and growth opportunity in these key regions, covering
North America
Europe
China
Japan
India
Southeast Asia
Other regions (Central & South America, Middle East & Africa)

We can also provide the customized separate regional or country-level reports, for the following regions:
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Rest of Asia-Pacific
Europe
Germany
France
UK
Italy
Spain
Russia
Rest of Europe
Central & South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Saudi Arabia
Turkey
Rest of Middle East & Africa

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
Murine Antibodies
Chimeric and Humanised Antibodies
Fully Humanized Antibodies
Others

By Application, the market can be split into
Liver
Breast
Blood
Brain
Hodgkins and Non-Hodgkins lymphoma
Colorectal
Leukaemia
Others

The study objectives of this report are:
To analyze and study the global Cancer Monoclonal Antibodies capacity, production, value, consumption, status (2013-2017) and forecast (2018-2025);
Focuses on the key Cancer Monoclonal Antibodies manufacturers, to study the capacity, production, value, market share and development plans in future.
Focuses on the global key manufacturers, to define, describe and analyze the market competition landscape, SWOT analysis.
To define, describe and forecast the market by type, application and region.
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends and factors driving or inhibiting the market growth.
To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
To strategically analyze each submarket with respect to individual growth trend and their contribution to the market.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Cancer Monoclonal Antibodies are as follows:
History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025

For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Key Stakeholders
Cancer Monoclonal Antibodies Manufacturers
Cancer Monoclonal Antibodies Distributors/Traders/Wholesalers
Cancer Monoclonal Antibodies Subcomponent Manufacturers
Industry Association
Downstream Vendors

Available Customizations
With the given market data, QYResearch offers customizations according to the company's specific needs. The following customization options are available for the report:
Regional and country-level analysis of the Cancer Monoclonal Antibodies market, by end-use.
Detailed analysis and profiles of additional market players.

Table of Contents

Global Cancer Monoclonal Antibodies Market Professional Survey Report 2018
1 Industry Overview of Cancer Monoclonal Antibodies
1.1 Definition and Specifications of Cancer Monoclonal Antibodies
1.1.1 Definition of Cancer Monoclonal Antibodies
1.1.2 Specifications of Cancer Monoclonal Antibodies
1.2 Classification of Cancer Monoclonal Antibodies
1.2.1 Murine Antibodies
1.2.2 Chimeric and Humanised Antibodies
1.2.3 Fully Humanized Antibodies
1.2.4 Others
1.3 Applications of Cancer Monoclonal Antibodies
1.3.1 Liver
1.3.2 Breast
1.3.3 Blood
1.3.4 Brain
1.3.5 Hodgkins and Non-Hodgkins lymphoma
1.3.6 Colorectal
1.3.7 Leukaemia
1.3.8 Others
1.4 Market Segment by Regions
1.4.1 North America
1.4.2 Europe
1.4.3 China
1.4.4 Japan
1.4.5 Southeast Asia
1.4.6 India

2 Manufacturing Cost Structure Analysis of Cancer Monoclonal Antibodies
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Cancer Monoclonal Antibodies
2.3 Manufacturing Process Analysis of Cancer Monoclonal Antibodies
2.4 Industry Chain Structure of Cancer Monoclonal Antibodies

3 Technical Data and Manufacturing Plants Analysis of Cancer Monoclonal Antibodies
3.1 Capacity and Commercial Production Date of Global Cancer Monoclonal Antibodies Major Manufacturers in 2017
3.2 Manufacturing Plants Distribution of Global Cancer Monoclonal Antibodies Major Manufacturers in 2017
3.3 R&D Status and Technology Source of Global Cancer Monoclonal Antibodies Major Manufacturers in 2017
3.4 Raw Materials Sources Analysis of Global Cancer Monoclonal Antibodies Major Manufacturers in 2017

4 Global Cancer Monoclonal Antibodies Overall Market Overview
4.1 2013-2018E Overall Market Analysis
4.2 Capacity Analysis
4.2.1 2013-2018E Global Cancer Monoclonal Antibodies Capacity and Growth Rate Analysis
4.2.2 2017 Cancer Monoclonal Antibodies Capacity Analysis (Company Segment)
4.3 Sales Analysis
4.3.1 2013-2018E Global Cancer Monoclonal Antibodies Sales and Growth Rate Analysis
4.3.2 2017 Cancer Monoclonal Antibodies Sales Analysis (Company Segment)
4.4 Sales Price Analysis
4.4.1 2013-2018E Global Cancer Monoclonal Antibodies Sales Price
4.4.2 2017 Cancer Monoclonal Antibodies Sales Price Analysis (Company Segment)

5 Cancer Monoclonal Antibodies Regional Market Analysis
5.1 North America Cancer Monoclonal Antibodies Market Analysis
5.1.1 North America Cancer Monoclonal Antibodies Market Overview
5.1.2 North America 2013-2018E Cancer Monoclonal Antibodies Local Supply, Import, Export, Local Consumption Analysis
5.1.3 North America 2013-2018E Cancer Monoclonal Antibodies Sales Price Analysis
5.1.4 North America 2017 Cancer Monoclonal Antibodies Market Share Analysis
5.2 Europe Cancer Monoclonal Antibodies Market Analysis
5.2.1 Europe Cancer Monoclonal Antibodies Market Overview
5.2.2 Europe 2013-2018E Cancer Monoclonal Antibodies Local Supply, Import, Export, Local Consumption Analysis
5.2.3 Europe 2013-2018E Cancer Monoclonal Antibodies Sales Price Analysis
5.2.4 Europe 2017 Cancer Monoclonal Antibodies Market Share Analysis
5.3 China Cancer Monoclonal Antibodies Market Analysis
5.3.1 China Cancer Monoclonal Antibodies Market Overview
5.3.2 China 2013-2018E Cancer Monoclonal Antibodies Local Supply, Import, Export, Local Consumption Analysis
5.3.3 China 2013-2018E Cancer Monoclonal Antibodies Sales Price Analysis
5.3.4 China 2017 Cancer Monoclonal Antibodies Market Share Analysis
5.4 Japan Cancer Monoclonal Antibodies Market Analysis
5.4.1 Japan Cancer Monoclonal Antibodies Market Overview
5.4.2 Japan 2013-2018E Cancer Monoclonal Antibodies Local Supply, Import, Export, Local Consumption Analysis
5.4.3 Japan 2013-2018E Cancer Monoclonal Antibodies Sales Price Analysis
5.4.4 Japan 2017 Cancer Monoclonal Antibodies Market Share Analysis
5.5 Southeast Asia Cancer Monoclonal Antibodies Market Analysis
5.5.1 Southeast Asia Cancer Monoclonal Antibodies Market Overview
5.5.2 Southeast Asia 2013-2018E Cancer Monoclonal Antibodies Local Supply, Import, Export, Local Consumption Analysis
5.5.3 Southeast Asia 2013-2018E Cancer Monoclonal Antibodies Sales Price Analysis
5.5.4 Southeast Asia 2017 Cancer Monoclonal Antibodies Market Share Analysis
5.6 India Cancer Monoclonal Antibodies Market Analysis
5.6.1 India Cancer Monoclonal Antibodies Market Overview
5.6.2 India 2013-2018E Cancer Monoclonal Antibodies Local Supply, Import, Export, Local Consumption Analysis
5.6.3 India 2013-2018E Cancer Monoclonal Antibodies Sales Price Analysis
5.6.4 India 2017 Cancer Monoclonal Antibodies Market Share Analysis

6 Global 2013-2018E Cancer Monoclonal Antibodies Segment Market Analysis (by Type)
6.1 Global 2013-2018E Cancer Monoclonal Antibodies Sales by Type
6.2 Different Types of Cancer Monoclonal Antibodies Product Interview Price Analysis
6.3 Different Types of Cancer Monoclonal Antibodies Product Driving Factors Analysis
6.3.1 Murine Antibodies Growth Driving Factor Analysis
6.3.2 Chimeric and Humanised Antibodies Growth Driving Factor Analysis
6.3.3 Fully Humanized Antibodies Growth Driving Factor Analysis
6.3.4 Others Growth Driving Factor Analysis

7 Global 2013-2018E Cancer Monoclonal Antibodies Segment Market Analysis (by Application)
7.1 Global 2013-2018E Cancer Monoclonal Antibodies Consumption by Application
7.2 Different Application of Cancer Monoclonal Antibodies Product Interview Price Analysis
7.3 Different Application of Cancer Monoclonal Antibodies Product Driving Factors Analysis
7.3.1 Liver of Cancer Monoclonal Antibodies Growth Driving Factor Analysis
7.3.2 Breast of Cancer Monoclonal Antibodies Growth Driving Factor Analysis
7.3.3 Blood of Cancer Monoclonal Antibodies Growth Driving Factor Analysis
7.3.4 Brain of Cancer Monoclonal Antibodies Growth Driving Factor Analysis
7.3.5 Hodgkins and Non-Hodgkins lymphoma of Cancer Monoclonal Antibodies Growth Driving Factor Analysis
7.3.6 Colorectal of Cancer Monoclonal Antibodies Growth Driving Factor Analysis
7.3.7 Leukaemia of Cancer Monoclonal Antibodies Growth Driving Factor Analysis
7.3.8 Others of Cancer Monoclonal Antibodies Growth Driving Factor Analysis

8 Major Manufacturers Analysis of Cancer Monoclonal Antibodies
8.1 F. Hoffmann-La Roche
8.1.1 Company Profile
8.1.2 Product Picture and Specifications
8.1.2.1 Product A
8.1.2.2 Product B
8.1.3 F. Hoffmann-La Roche 2017 Cancer Monoclonal Antibodies Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.1.4 F. Hoffmann-La Roche 2017 Cancer Monoclonal Antibodies Business Region Distribution Analysis
8.2 Amgen
8.2.1 Company Profile
8.2.2 Product Picture and Specifications
8.2.2.1 Product A
8.2.2.2 Product B
8.2.3 Amgen 2017 Cancer Monoclonal Antibodies Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.2.4 Amgen 2017 Cancer Monoclonal Antibodies Business Region Distribution Analysis
8.3 Bristol-Myers Squibb
8.3.1 Company Profile
8.3.2 Product Picture and Specifications
8.3.2.1 Product A
8.3.2.2 Product B
8.3.3 Bristol-Myers Squibb 2017 Cancer Monoclonal Antibodies Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.3.4 Bristol-Myers Squibb 2017 Cancer Monoclonal Antibodies Business Region Distribution Analysis
8.4 Takeda Pharmaceuticals
8.4.1 Company Profile
8.4.2 Product Picture and Specifications
8.4.2.1 Product A
8.4.2.2 Product B
8.4.3 Takeda Pharmaceuticals 2017 Cancer Monoclonal Antibodies Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.4.4 Takeda Pharmaceuticals 2017 Cancer Monoclonal Antibodies Business Region Distribution Analysis

9 Development Trend of Analysis of Cancer Monoclonal Antibodies Market
9.1 Global Cancer Monoclonal Antibodies Market Trend Analysis
9.1.1 Global 2018-2025 Cancer Monoclonal Antibodies Market Size (Volume and Value) Forecast
9.1.2 Global 2018-2025 Cancer Monoclonal Antibodies Sales Price Forecast
9.2 Cancer Monoclonal Antibodies Regional Market Trend
9.2.1 North America 2018-2025 Cancer Monoclonal Antibodies Consumption Forecast
9.2.2 Europe 2018-2025 Cancer Monoclonal Antibodies Consumption Forecast
9.2.3 China 2018-2025 Cancer Monoclonal Antibodies Consumption Forecast
9.2.4 Japan 2018-2025 Cancer Monoclonal Antibodies Consumption Forecast
9.2.5 Southeast Asia 2018-2025 Cancer Monoclonal Antibodies Consumption Forecast
9.2.6 India 2018-2025 Cancer Monoclonal Antibodies Consumption Forecast
9.3 Cancer Monoclonal Antibodies Market Trend (Product Type)
9.4 Cancer Monoclonal Antibodies Market Trend (Application)

10 Cancer Monoclonal Antibodies Marketing Type Analysis
10.1 Cancer Monoclonal Antibodies Regional Marketing Type Analysis
10.2 Cancer Monoclonal Antibodies International Trade Type Analysis
10.3 Traders or Distributors with Contact Information of Cancer Monoclonal Antibodies by Region
10.4 Cancer Monoclonal Antibodies Supply Chain Analysis

11 Consumers Analysis of Cancer Monoclonal Antibodies
11.1 Consumer 1 Analysis
11.2 Consumer 2 Analysis
11.3 Consumer 3 Analysis
11.4 Consumer 4 Analysis

12 Conclusion of the Global Cancer Monoclonal Antibodies Market Professional Survey Report 2017
Methodology
Analyst Introduction
Data Source

List of Tables and Figures
Figure Picture of Cancer Monoclonal Antibodies
Table Product Specifications of Cancer Monoclonal Antibodies
Table Classification of Cancer Monoclonal Antibodies
Figure Global Production Market Share of Cancer Monoclonal Antibodies by Type in 2017
Figure Murine Antibodies Picture
Table Major Manufacturers of Murine Antibodies
Figure Chimeric and Humanised Antibodies Picture
Table Major Manufacturers of Chimeric and Humanised Antibodies
Figure Fully Humanized Antibodies Picture
Table Major Manufacturers of Fully Humanized Antibodies
Figure Others Picture
Table Major Manufacturers of Others
Table Applications of Cancer Monoclonal Antibodies
Figure Global Consumption Volume Market Share of Cancer Monoclonal Antibodies by Application in 2017
Figure Liver Examples
Table Major Consumers in Liver
Figure Breast Examples
Table Major Consumers in Breast
Figure Blood Examples
Table Major Consumers in Blood
Figure Brain Examples
Table Major Consumers in Brain
Figure Hodgkins and Non-Hodgkins lymphoma Examples
Table Major Consumers in Hodgkins and Non-Hodgkins lymphoma
Figure Colorectal Examples
Table Major Consumers in Colorectal
Figure Leukaemia Examples
Table Major Consumers in Leukaemia
Figure Others Examples
Table Major Consumers in Others
Figure Market Share of Cancer Monoclonal Antibodies by Regions
Figure North America Cancer Monoclonal Antibodies Market Size (Million USD) (2013-2025)
Figure Europe Cancer Monoclonal Antibodies Market Size (Million USD) (2013-2025)
Figure China Cancer Monoclonal Antibodies Market Size (Million USD) (2013-2025)
Figure Japan Cancer Monoclonal Antibodies Market Size (Million USD) (2013-2025)
Figure Southeast Asia Cancer Monoclonal Antibodies Market Size (Million USD) (2013-2025)
Figure India Cancer Monoclonal Antibodies Market Size (Million USD) (2013-2025)
Table Cancer Monoclonal Antibodies Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Cancer Monoclonal Antibodies in 2017
Figure Manufacturing Process Analysis of Cancer Monoclonal Antibodies
Figure Industry Chain Structure of Cancer Monoclonal Antibodies
Table Capacity and Commercial Production Date of Global Cancer Monoclonal Antibodies Major Manufacturers in 2017
Table Manufacturing Plants Distribution of Global Cancer Monoclonal Antibodies Major Manufacturers in 2017
Table R&D Status and Technology Source of Global Cancer Monoclonal Antibodies Major Manufacturers in 2017
Table Raw Materials Sources Analysis of Global Cancer Monoclonal Antibodies Major Manufacturers in 2017
Table Global Capacity, Sales , Price, Cost, Sales Revenue (M USD) and Gross Margin of Cancer Monoclonal Antibodies 2013-2018E
Figure Global 2013-2018E Cancer Monoclonal Antibodies Market Size (Volume) and Growth Rate
Figure Global 2013-2018E Cancer Monoclonal Antibodies Market Size (Value) and Growth Rate
Table 2013-2018E Global Cancer Monoclonal Antibodies Capacity and Growth Rate
Table 2017 Global Cancer Monoclonal Antibodies Capacity (K Units) List (Company Segment)
Table 2013-2018E Global Cancer Monoclonal Antibodies Sales (K Units) and Growth Rate
Table 2017 Global Cancer Monoclonal Antibodies Sales (K Units) List (Company Segment)
Table 2013-2018E Global Cancer Monoclonal Antibodies Sales Price (USD/Unit)
Table 2017 Global Cancer Monoclonal Antibodies Sales Price (USD/Unit) List (Company Segment)
Figure North America Capacity Overview
Table North America Supply, Import, Export and Consumption (K Units) of Cancer Monoclonal Antibodies 2013-2018E
Figure North America 2013-2018E Cancer Monoclonal Antibodies Sales Price (USD/Unit)
Figure North America 2017 Cancer Monoclonal Antibodies Sales Market Share
Figure Europe Capacity Overview
Table Europe Supply, Import, Export and Consumption (K Units) of Cancer Monoclonal Antibodies 2013-2018E
Figure Europe 2013-2018E Cancer Monoclonal Antibodies Sales Price (USD/Unit)
Figure Europe 2017 Cancer Monoclonal Antibodies Sales Market Share
Figure China Capacity Overview
Table China Supply, Import, Export and Consumption (K Units) of Cancer Monoclonal Antibodies 2013-2018E
Figure China 2013-2018E Cancer Monoclonal Antibodies Sales Price (USD/Unit)
Figure China 2017 Cancer Monoclonal Antibodies Sales Market Share
Figure Japan Capacity Overview
Table Japan Supply, Import, Export and Consumption (K Units) of Cancer Monoclonal Antibodies 2013-2018E
Figure Japan 2013-2018E Cancer Monoclonal Antibodies Sales Price (USD/Unit)
Figure Japan 2017 Cancer Monoclonal Antibodies Sales Market Share
Figure Southeast Asia Capacity Overview
Table Southeast Asia Supply, Import, Export and Consumption (K Units) of Cancer Monoclonal Antibodies 2013-2018E
Figure Southeast Asia 2013-2018E Cancer Monoclonal Antibodies Sales Price (USD/Unit)
Figure Southeast Asia 2017 Cancer Monoclonal Antibodies Sales Market Share
Figure India Capacity Overview
Table India Supply, Import, Export and Consumption (K Units) of Cancer Monoclonal Antibodies 2013-2018E
Figure India 2013-2018E Cancer Monoclonal Antibodies Sales Price (USD/Unit)
Figure India 2017 Cancer Monoclonal Antibodies Sales Market Share
Table Global 2013-2018E Cancer Monoclonal Antibodies Sales (K Units) by Type
Table Different Types Cancer Monoclonal Antibodies Product Interview Price
Table Global 2013-2018E Cancer Monoclonal Antibodies Sales (K Units) by Application
Table Different Application Cancer Monoclonal Antibodies Product Interview Price
Table F. Hoffmann-La Roche Information List
Table Product Overview
Table 2017 F. Hoffmann-La Roche Cancer Monoclonal Antibodies Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2017 F. Hoffmann-La Roche Cancer Monoclonal Antibodies Business Region Distribution
Table Amgen Information List
Table Product Overview
Table 2017 Amgen Cancer Monoclonal Antibodies Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2017 Amgen Cancer Monoclonal Antibodies Business Region Distribution
Table Bristol-Myers Squibb Information List
Table Product Overview
Table 2017 Bristol-Myers Squibb Cancer Monoclonal Antibodies Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2017 Bristol-Myers Squibb Cancer Monoclonal Antibodies Business Region Distribution
Table Takeda Pharmaceuticals Information List
Table Product Overview
Table 2017 Takeda Pharmaceuticals Cancer Monoclonal Antibodies Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2017 Takeda Pharmaceuticals Cancer Monoclonal Antibodies Business Region Distribution
Figure Global 2018-2025 Cancer Monoclonal Antibodies Market Size (K Units) and Growth Rate Forecast
Figure Global 2018-2025 Cancer Monoclonal Antibodies Market Size (Million USD) and Growth Rate Forecast
Figure Global 2018-2025 Cancer Monoclonal Antibodies Sales Price (USD/Unit) Forecast
Figure North America 2018-2025 Cancer Monoclonal Antibodies Consumption Volume (K Units) and Growth Rate Forecast
Figure China 2018-2025 Cancer Monoclonal Antibodies Consumption Volume (K Units) and Growth Rate Forecast
Figure Europe 2018-2025 Cancer Monoclonal Antibodies Consumption Volume (K Units) and Growth Rate Forecast
Figure Southeast Asia 2018-2025 Cancer Monoclonal Antibodies Consumption Volume (K Units) and Growth Rate Forecast
Figure Japan 2018-2025 Cancer Monoclonal Antibodies Consumption Volume (K Units) and Growth Rate Forecast
Figure India 2018-2025 Cancer Monoclonal Antibodies Consumption Volume (K Units) and Growth Rate Forecast
Table Global Sales Volume (K Units) of Cancer Monoclonal Antibodies by Type 2018-2025
Table Global Consumption Volume (K Units) of Cancer Monoclonal Antibodies by Application 2018-2025
Table Traders or Distributors with Contact Information of Cancer Monoclonal Antibodies by Region

Choose License Type